Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer

Table 2

The parameters of the OPLS-DA models.

Group	R^2X	R^2Y	Q^2
NSCLC vs HC	0.296	0.803	0.739
NSCLC vs LBD	0.255	0.706	0.481
LBD vs HC	0.263	0.883	0.762

NSCLC, non-small cell lung cancer; LBD, lung benign disease; HC, healthy controls.